JP2024513690A5 - - Google Patents

Info

Publication number
JP2024513690A5
JP2024513690A5 JP2023555752A JP2023555752A JP2024513690A5 JP 2024513690 A5 JP2024513690 A5 JP 2024513690A5 JP 2023555752 A JP2023555752 A JP 2023555752A JP 2023555752 A JP2023555752 A JP 2023555752A JP 2024513690 A5 JP2024513690 A5 JP 2024513690A5
Authority
JP
Japan
Prior art keywords
active substance
mammal
infestation
fleas
ticks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023555752A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024513690A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/019913 external-priority patent/WO2022192648A1/en
Publication of JP2024513690A publication Critical patent/JP2024513690A/ja
Publication of JP2024513690A5 publication Critical patent/JP2024513690A5/ja
Pending legal-status Critical Current

Links

JP2023555752A 2021-03-11 2022-03-11 哺乳動物におけるノミおよびダニの侵入を制御する方法 Pending JP2024513690A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163159801P 2021-03-11 2021-03-11
US63/159,801 2021-03-11
PCT/US2022/019913 WO2022192648A1 (en) 2021-03-11 2022-03-11 Methods for controlling flea and tick infestations in a mammal

Publications (2)

Publication Number Publication Date
JP2024513690A JP2024513690A (ja) 2024-03-27
JP2024513690A5 true JP2024513690A5 (cg-RX-API-DMAC7.html) 2025-03-06

Family

ID=83227137

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023555752A Pending JP2024513690A (ja) 2021-03-11 2022-03-11 哺乳動物におけるノミおよびダニの侵入を制御する方法

Country Status (10)

Country Link
US (1) US20230413819A1 (cg-RX-API-DMAC7.html)
EP (1) EP4304722A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024513690A (cg-RX-API-DMAC7.html)
KR (1) KR20230161996A (cg-RX-API-DMAC7.html)
CN (1) CN117500498A (cg-RX-API-DMAC7.html)
AU (1) AU2022234415A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023017666A2 (cg-RX-API-DMAC7.html)
CA (1) CA3211582A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023010380A (cg-RX-API-DMAC7.html)
WO (1) WO2022192648A1 (cg-RX-API-DMAC7.html)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001011963A1 (en) * 1999-08-12 2001-02-22 Eli Lilly And Company Oral treatment of companion animals with ectoparasiticidal spinosyns
CA2544417C (en) * 2003-11-04 2012-04-10 Akzo Nobel N.V. Ectoparasiticidal formulations of spinosyns and azole pesticides
UA108200C2 (uk) * 2009-05-08 2015-04-10 Лікарські форми та способи застосування ектопаразитоцидів
WO2010150100A1 (en) * 2009-06-24 2010-12-29 Entarco Sa The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer
WO2012155352A1 (en) * 2011-05-19 2012-11-22 Eli Lilly And Company Dihydroisoxazole compounds, parasiticidal uses and formulations thereof
WO2020201440A1 (en) * 2019-04-03 2020-10-08 Virbac Low dose fluralaner compositions for protection against parasitic invertebrate pest

Similar Documents

Publication Publication Date Title
JP2022527398A5 (cg-RX-API-DMAC7.html)
JP6530753B2 (ja) イソオキサゾリン化合物の抗寄生生物薬使用
FI3952880T3 (fi) 2-(2,6-dioksopiperidin-3-yyli)-4-((2-fluori-4-((3-morfolinoatsetidin-1-yyli)metyyli)bentsyyli)amino)isoindoliini-1,3-dioni käytettäväksi non-hodgkinin lymfooman hoidossa
JP2022554276A5 (cg-RX-API-DMAC7.html)
JP2014533735A (ja) 外寄生生物を防除するためのアリール誘導体の使用
JP2019517587A5 (cg-RX-API-DMAC7.html)
FI3007695T3 (fi) Koostumuksia ja menetelmiä anemian hoitamiseksi
JPWO2023054732A5 (cg-RX-API-DMAC7.html)
JPH01139529A (ja) 歯周病治療剤及び歯周病治療用組成物
JP2021525757A5 (cg-RX-API-DMAC7.html)
JP2021516241A5 (cg-RX-API-DMAC7.html)
EP1689382A1 (de) Pharmazeutische zusammensetzung aus einem beta-3-adrenozeptor-agonisten und einem in den prostaglandinstoffwechsel eingreifendem wirkstoff
JP2013536837A5 (cg-RX-API-DMAC7.html)
DK161669B (da) Synergistisk farmaceutisk praeparat til behandling af depressive symtomer, fremgangsmaade til dets fremstilling og anvendelse af den fremstillede blanding til praeparatets fremstilling
JP2023502053A5 (cg-RX-API-DMAC7.html)
JP2024511953A5 (cg-RX-API-DMAC7.html)
CN114072401A (zh) 作为irak4和btk多靶点抑制剂的噁唑类化合物
JP2024524996A5 (cg-RX-API-DMAC7.html)
JP2021521227A5 (cg-RX-API-DMAC7.html)
JP2024524933A5 (cg-RX-API-DMAC7.html)
IL276437B2 (en) Use of 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-n-{4-[(s-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine for treating diffuse large b-cell lymphoma
EP0219728B1 (de) Kombinationspräparat
EP0472033A2 (de) 3,5-Diiod-L-Thyronin zur TSH-Suppression und Behandlung von Struma
JP2024543347A5 (cg-RX-API-DMAC7.html)
JP2024506041A5 (cg-RX-API-DMAC7.html)